The first chikungunya vaccine may be on its way with phase 3 trials of a single-shot jab developed by French biotech company Valneva showing the vaccine to be generally safe, well tolerated and provoking an immune response. The study was conducted in the US. Its success will have significant implications for nations like India where chikungunya is endemic.
from Times of India https://ift.tt/YQn7WAp
Monday, 12 June 2023
Tags
# Top Stories
About gk4u
Bollywood News And Much More In Gujarati Language. Gujarati Literature. Excellent Coverage. Premium Content. Most Accurate. Types: Business, Politics, Entertainment.Breaking News In Hindi, Samachar (समाचार) And News Headlines From India, Current Affairs, Cricket, Sports,Today's Breaking News. Movie Reviews. Expert's Opinion. Cricket Highlights. Free FP Shows. Shows: Bowled Over, Our Better World, Web Talkies, 9 Months, India Unheard, 101 India. .
Newer Article
NIA seeks info on those involved in violent protest at Indian Mission in London
Older Article
Three British tourists perish after boat catches fire off Egypt's Red Sea coast, tour company says
Subscribe to:
Post Comments (Atom)
Bollywood News And Much More In Gujarati Language. Gujarati Literature. Excellent Coverage. Premium Content. Most Accurate
No comments:
Post a Comment